|
|
|
|
|
|
|
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 106, Issue 1 423-430, Copyright © 1993 by Company of Biologists
JOURNAL ARTICLES |
JJ Turek, CP Leamon and PS Low
Department of Veterinary Anatomy, Purdue University, West Lafayette, IN 47907.
It has been demonstrated that proteins covalently conjugated to folic acid may be taken up by cells via endocytosis after binding to a folate binding protein (FBP) in the cell membrane. The proteins taken up in this manner remain catalytically active and they may modify physiological processes occurring in the cytosol. Confocal fluorescence microscopy of KB cells incubated with FITC-bovine serum albumin-folic acid conjugates showed that after uptake, the conjugates resided in large vesicular structures. The purpose of the present study was to determine the subcellular localization of protein-folic acid conjugates in KB cells using folic acid-bovine serum albumin-colloidal gold (F-BSA-CG) as a tracer. F-BSA-CG conjugates were taken up via uncoated pits or caveolae, and resided primarily in multivesicular bodies (MVBs) and other tubular endosomes at early time points (15-60 min). At later time points (6 hours), conjugates were still contained in MVBs but some were also found in secondary lysosomes or free in the cytoplasm. Coincubation of KB cells with transferrin-colloidal gold (TF-CG) and F-BSA-CG resulted in colocalization of TF-CG and F-BSA-CG within endosomal elements at times later than 15 minutes, indicating that the caveolae-mediated F-BSA-CG endocytic pathway converged with a pathway utilized by clathrin-coated pits.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  J. Yang, H. Chen, I. R. Vlahov, J.-X. Cheng, and P. S. Low Characterization of the pH of Folate Receptor-Containing Endosomes and the Rate of Hydrolysis of Internalized Acid-Labile Folate-Drug Conjugates J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 462 - 468. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Yang, H. Chen, I. R. Vlahov, J.-X. Cheng, and P. S. Low Evaluation of disulfide reduction during receptor-mediated endocytosis by using FRET imaging PNAS, September 12, 2006; 103(37): 13872 - 13877. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. F. Kukowska-Latallo, K. A. Candido, Z. Cao, S. S. Nigavekar, I. J. Majoros, T. P. Thomas, L. P. Balogh, M. K. Khan, and J. R. Baker Jr. Nanoparticle Targeting of Anticancer Drug Improves Therapeutic Response in Animal Model of Human Epithelial Cancer Cancer Res., June 15, 2005; 65(12): 5317 - 5324. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Paulos, J. A. Reddy, C. P. Leamon, M. J. Turk, and P. S. Low Ligand Binding and Kinetics of Folate Receptor Recycling in Vivo: Impact on Receptor-Mediated Drug Delivery Mol. Pharmacol., December 1, 2004; 66(6): 1406 - 1414. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Sandoval, M. D. Kennedy, P. S. Low, and B. A. Molitoris Uptake and trafficking of fluorescent conjugates of folic acid in intact kidney determined using intravital two-photon microscopy Am J Physiol Cell Physiol, August 1, 2004; 287(2): C517 - C526. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Wang, X. Zheng, F. G. Behm, and M. Ratnam Differentiation-independent retinoid induction of folate receptor type beta , a potential tumor target in myeloid leukemia Blood, November 15, 2000; 96(10): 3529 - 3536. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Wu, W. Gunning, and M. Ratnam Expression of Folate Receptor Type {{alpha}} in Relation to Cell Type, Malignancy, and Differentiation in Ovary, Uterus, and Cervix Cancer Epidemiol. Biomarkers Prev., September 1, 1999; 8(9): 775 - 782. [Abstract] [Full Text]
|
|
|
|
|
|
A. Subtil, I. Gaidarov, K. Kobylarz, M. A. Lampson, J. H. Keen, and T. E. McGraw Acute cholesterol depletion inhibits clathrin-coated pit budding PNAS, June 8, 1999; 96(12): 6775 - 6780. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Maziarz, H. L. Monaco, F. Shen, and M. Ratnam Complete Mapping of Divergent Amino Acids Responsible for Differential Ligand Binding of Folate Receptors alpha and beta J. Biol. Chem., April 16, 1999; 274(16): 11086 - 11091. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Gilbert, J. Paccaud, M Foti, G Porcheron, J Balz, and J. Carpentier Direct demonstration of the endocytic function of caveolae by a cell-free assay J. Cell Sci., January 4, 1999; 112(7): 1101 - 1110. [Abstract] [PDF]
|
|
|
|
|
|
L. J. Schedlich, T. F. Young, S. M. Firth, and R. C. Baxter Insulin-like Growth Factor-binding Protein (IGFBP)-3 and IGFBP-5 Share a Common Nuclear Transport Pathway in T47D Human Breast Carcinoma Cells J. Biol. Chem., July 17, 1998; 273(29): 18347 - 18352. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U Vogel, K Sandvig, and B van Deurs Expression of caveolin-1 and polarized formation of invaginated caveolae in Caco-2 and MDCK II cells J. Cell Sci., January 3, 1998; 111(6): 825 - 832. [Abstract] [PDF]
|
|
|
|
|
|
C. Bouillot, A. Prochiantz, G.èv. Rougon, and B. Allinquant Axonal Amyloid Precursor Protein Expressed by Neurons in Vitro Is Present in a Membrane Fraction with Caveolae-like Properties J. Biol. Chem., March 29, 1996; 271(13): 7640 - 7644. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. F. Atkinson, T. Bettinger, L. W. Seymour, J.-P. Behr, and C. M. Ward Conjugation of Folate via Gelonin Carbohydrate Residues Retains Ribosomal-inactivating Properties of the Toxin and Permits Targeting to Folate Receptor Positive Cells J. Biol. Chem., July 20, 2001; 276(30): 27930 - 27935. [Abstract] [Full Text] [PDF]
|
|
